Extended Data Fig. 8: Senolysis as a novel treatment concept in COVID-19 patients.
From: Virus-induced senescence is a driver and therapeutic target in COVID-19
a, Frequency (bars) and risk (odds ratio) of COVID-19 patients to be hospitalized or in need of oxygen support after either standard care (SC) or quercetin plus standard care (Quercetin). n = 97 for each group, based on two randomized trials combined and re-analysed here51,52. b, Days of hospitalization (left) of COVID-19 patients (left; *p < 0.0001 by unpaired t-test, two-tailed), the fraction of patients admitted to the intensive care unit (ICU; middle) or deceased in the course of the disease (right). Note that there was no patient in ICU or deceased in the quercetin group. Patients as in a; n = 97 for each group.
